BOM/544644 (BOM/544644)

Bombay Stock Exchange: BOM/544644 · INR

₹2,198

+47.05 (+2.2%)· Recorded snapshot

Market cap	134.6B
Revenue (ttm)	14.8B
Net income (ttm)	2B
EPS (ttm)	₹32.5
P/E (trailing)	67.5x
P/E (forward)	52.0x
Dividend	₹10.0 (0.46%)
Volume	3,345

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.8B
Net income (ttm): 2B
EPS (ttm): ₹32.5
P/E (trailing): 67.5x
P/E (forward): 52.0x
Market cap: 134.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E52

P25 n/aP50 n/aP75 n/a

Trailing P/E67.5

P25 n/aP50 n/aP75 n/a

ROE27.4

P25 n/aP50 n/aP75 n/a

ROIC23.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/544644 indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

INR

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-30
Employees	5,153
Employees change	645
Employees growth	14.31%
Enterprise value	INR 135.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2004
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	INE02ZQ01018
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	INR 134.6B
Next earnings date	2026-10-30
Price	INR 2,197.90
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/544644
Website	https://www.coronaremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.48%
EV/Earnings	68.31x
EV/EBIT	49.32x
EV/EBITDA	43.33x
EV/FCF	245.62x
EV/Sales	9.19x
FCF / EV yield	0.41%
FCF yield	0.41%
Forward P/E	52.04x
Graham number	298.65435
Graham upside	-86.41%
Industry forward P/E	32.11x
Industry P/E	38.96x
P/B ratio	18.02x
P/E ratio	67.53x
P/FCF ratio	243.16x
P/OCF ratio	58.65x
P/S ratio	9.1x
Price / tangible book value	27.81x
Price/EBITDA ratio	43.43x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.6%
EBITDA margin	20.95%
Effective tax rate	23.48%
FCF margin	3.94%
Gross margin	80.82%
Operating margin	18.6%
Pretax margin	17.58%
Profit margin	13.46%
Profit per employee	INR 386,241
Revenue per employee	INR 2.9M
ROA	15%
ROA (5Y)	10.51%
ROCE	30.35%
ROE	27.36%
ROE (5Y)	19.68%
ROIC	23.85%
ROIC (5Y)	17.96%
Tax / revenue	4.13%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.09%
EPS growth (Q)	30.2%
EPS growth (QoQ)	32.66%
FCF growth	-44%
Gross profit growth	20.48%
Gross profit growth (Q)	23.56%
Net income growth	25.05%
Net income growth (Q)	30.12%
Net income growth (QoQ)	32.61%
OCF growth	20.47%
Operating income growth	27.9%
Operating income growth (Q)	30.9%
Revenue growth	19.24%
Revenue growth (Q)	21.9%
Revenue growth (QoQ)	19.64%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -1.7B
Depreciation and amortization	INR 347.3M
EBIT	INR 2.8B
EBITDA	INR 3.1B
EPS	INR 32.55
Financing cash flow	INR 252.8M
Free cash flow	INR 553.5M
Gross profit	INR 12B
Income taxes	INR 610.6M
Investing cash flow	INR -2.6B
Net borrowing	INR 773.8M
Net cash flow	INR -13.9M
Net income	INR 2B
Operating income	INR 2.8B
Revenue	INR 14.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 122.12
Debt / EBITDA	0.53
Debt / equity	0.22
Debt / FCF	2.98
Interest coverage	37.18
Net cash (debt)	INR -1.4B
Net cash / market cap	-1.01%
Net debt / EBITDA	0.44
Net debt / equity	0.18
Net debt / FCF	2.46
Piotroski F-Score	5
Shareholders' equity	INR 7.5B
Tangible book value	INR 4.8B
Tangible book value per share	INR 79.14
Total cash	INR 288.3M
Total debt	INR 1.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.31
Current ratio	0.96
Inventory turnover	2.14
Quick ratio	0.49
Working capital	INR -128.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.01%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-07
Dividend payment years	1
Dividend per share	INR 10.00
Dividend yield	0.46%
Ex-dividend date	2026-06-19
Last dividend	INR 10.00
Payout ratio	30.72%
Shareholder yield	0.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 1,911.19
1D price change	2.19%
1M price change	3.9%
1M total return	3.9%
1W price change	9.26%
1W total return	9.26%
20-day SMA	INR 2,049.48
200-day SMA	INR 1,814.73
3M price change	4.96%
3M total return	4.96%
50-day SMA	INR 2,097.88
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,285.00
52-week high date	2026-09-15
52-week low	INR 1,336.95
52-week low date	2025-12-23
6M price change	30.37%
6M total return	31.08%
All-time high	INR 2,285.00
All-time high date	2026-09-15
All-time low	INR 1,336.95
All-time low date	2025-12-23
Average true range (ATR)	INR 63.24
Average volume	4.1K
Change from 52-week high	-3.81%
Change from 52-week low	64.4%
Change from all-time high	-3.81%
Change from all-time low	64.4%
Change from open	-0.73%
Day's gap	2.94%
Dollar volume	INR 7.4M
High price	INR 2,214.00
Low price	INR 2,151.00
Monthly RSI	0
Open price	INR 2,214.00
Position in 52-week range	74.44%
Previous close	INR 2,150.85
Price vs 150-day SMA	15%
Price vs 20-day SMA	7.24%
Price vs 200-day SMA	21.11%
Price vs 50-day SMA	4.77%
Relative volume	0.84
RSI	65.3
Sharpe ratio	1.61
Sortino ratio	2.67
Volume	3.3K
Weekly RSI	64.61
YTD price change	58.6%
YTD total return	59.47%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.4M
Shares change (QoQ)	-0.04%
Shares change (YoY)	-0.01%
Shares held by insiders	69%
Shares held by institutions	11.67%

Deeper analysis on BOM/544644

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/544644 report

Is a complete BOM/544644 research report available?

No complete published report is available for bom/544644 (BOM/544644) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/544644 (BOM/544644)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/544644

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/544644 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/544644

Frequently asked questions